Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,373
Award facts
- Contract value 100% obligated
- $87,373.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,373.40 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 200 mg/1.14 mL syringes on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract falls under a larger indefinite delivery contract vehicle with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which enables comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal medical procurement. The company maintains significant capacity to supply a wide range of medical products, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The delivery of Dupixent—a biologic immunosuppressant used primarily to treat moderate-to-severe eczema, asthma, and other inflammatory conditions—reflects AmerisourceBergen's established role in supporting the Defense Health Agency and other federal healthcare systems with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26F5Z37?
SPE2DR26F5Z37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5Z37 worth?
The government has obligated $87,373 on SPE2DR26F5Z37.
Is contract SPE2DR26F5Z37 an order under another contract?
Yes. SPE2DR26F5Z37 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z37 competed?
The extent of competition for SPE2DR26F5Z37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award